Declines in Mortality Rates and Changes in Causes of Death in HIV-1-Infected Children During the HAART Era
- 1 January 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 53 (1), 86-94
- https://doi.org/10.1097/qai.0b013e3181b9869f
Abstract
Context: Introduction of highly active antiretroviral therapy has significantly decreased mortality in HIV-1-infected adults and children. Although an increase in non-HIV-related mortality has been noted in adults, data in children are limited. Objectives: To evaluate changes in causes and risk factors for death among HIV-1-infected children in Pediatric AIDS Clinical Trials Group 219/219C. Design, Setting, and Participants: Multicenter, prospective cohort study designed to evaluate long-term outcomes in HIV-1-exposed and infected US children. There were 3553 HIV-1-infected children enrolled and followed up between April 1993 and December 2006, with primary cause of mortality identified in the 298 observed deaths. Main Outcome Measures: Mortality rates per 100 child-years overall and by demographic factors; survival estimates by birth cohort; and hazard ratios for mortality by various demographic, health, and antiretroviral treatment factors were determined. Results: Among 3553 HIV-1-infected children followed up for a median of 5.3 years, 298 deaths occurred. Death rates significantly decreased between 1994 and 2000, from 7.2 to 0.8 per 100 person-years, and remained relatively stable through 2006. After adjustment for other covariates, increased risk of death was identified for those with low CD4 and AIDS-defining illness at entry. Decreased risks of mortality were identified for later birth cohorts, and for time-dependent initiation of highly active antiretroviral therapy (hazard ratio 0.54, P < 0.001). The most common causes of death were “End-stage AIDS” (N = 48, 16%) and pneumonia (N = 41, 14%). The proportion of deaths due to opportunistic infections (OIs) declined from 37% in 1994-1996 to 24% after 2000. All OI mortality declined during the study period. However, a greater decline was noted for deaths due to Mycobacterium avium complex and cryptosporidium. Deaths from “End-stage AIDS,” sepsis and renal failure increased. Conclusions: Overall death rates declined from 1993 to 2000 but have since stabilized at rates about 30 times higher than for the general US pediatric population. Deaths due to OIs have declined, but non-AIDS-defining infections and multiorgan failure remain major causes of mortality in HIV-1-infected children.Keywords
This publication has 28 references indexed in Scilit:
- Early Antiretroviral Therapy and Mortality among HIV-Infected InfantsNew England Journal of Medicine, 2008
- Do-Not-Resuscitate Orders and/or Hospice Care, Psychological Health, and Quality of Life among Children/Adolescents with Acquired Immune Deficiency SyndromeJournal of Palliative Medicine, 2008
- Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected childrenJournal of Medical Virology, 2007
- Treating Children with HIV Infection: What We Can Do, We Should DoClinical Infectious Diseases, 2007
- When should we treat children with HIV?Jornal de Pediatria, 2006
- A 20-year history of childhood HIV-associated nephropathyPediatric Nephrology, 2004
- Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999The Pediatric Infectious Disease Journal, 2003
- Aging cohort of perinatally human immunodeficiency virus-infected children in New York CityThe Pediatric Infectious Disease Journal, 2001
- Morbidity and Mortality in European Children Vertically Infected by HIV-1JAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Renal Disease in Children with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989